NEOGENOMICS INC — Director's Dealing 2021

Jun 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-06-08

Reporting Person: CROWTHER BRUCE K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-08	Common Stock	M	10000	$7.27	Acquired	59564	Direct
2021-06-08	Common Stock	M	3017	$11.60	Acquired	62581	Direct
2021-06-08	Common Stock	M	4269	$22.52	Acquired	66850	Direct
2021-06-08	Common Stock	M	3448	$28.54	Acquired	70298	Direct
2021-06-08	Common Stock	S	20734	$41.46	Disposed	49564	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-08	Stock Option (Right to Buy)	$7.27	M	10000	Disposed	2022-05-25	Common Stock (10000.0)	Direct
2021-06-08	Stock Option (Right to Buy)	$11.6	M	3017	Disposed	2023-06-01	Common Stock (3017.0)	Direct
2021-06-08	Stock Option (Right to Buy)	$22.52	M	4269	Disposed	2026-06-06	Common Stock (4269.0)	Direct
2021-06-08	Stock Option (Right to Buy)	$28.54	M	3448	Disposed	2027-05-28	Common Stock (3448.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$40.9	2028-06-02	Common Stock (3714.0)	3714	Direct

Footnotes

F1: On May 25, 2017, Mr. Crowther was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.